Antibody

1,032개 · ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved1,032 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

AntibodyLimited DatastaleNational Cancer Institute (NCI)Phase 2

cixutumumab (cixutumumab)

Recurrent Non-small Cell Lung Cancer; Stage IIIB Non-small Cell Lung Cancer · Recurrent Non-small Cell Lung Cancer

#RecurrentNon-smallCellLungCancer#Antibody#Phase2#monoclonal-antibody#StageIIIBNon-smallCellLungCancer+1
Trials 1Status Active
AntibodyLimited DatastaleJanssenApproved

daclizumab, infliximab (daclizumab, infliximab)

Graft vs Host Disease · Graft vs Host Disease

#GraftvsHostDisease#Antibody#Approved#monoclonal-antibody#Janssen
Trials 1Status Active
AntibodyLimited DatastaleSaglik Bilimleri UniversitesiPreclinical

ranibizumab (Lucentis, dexamethasone implant versus ranibizumab)

Diabetic Macular Edema; Inflammation · Diabetic Macular Edema

#DiabeticMacularEdema#Antibody#Preclinical#monoclonal-antibody#Inflammation+1
Trials 1Status Active
AntibodyLimited DatastaleStanford UniversityPhase 1

dupliumab (dupliumab)

Eosinophilic Disorder; Food Allergy · Eosinophilic Disorder

#EosinophilicDisorder#Antibody#Phase1#monoclonal-antibody#FoodAllergy+1
Trials 1Status Discontinued
AntibodyLimited DatastaleRocheApproved

eltrombopag combining rituximab (eltrombopag combining rituximab)

Primary Immune Thrombocytopenia (ITP) · Primary Immune Thrombocytopenia (ITP)

#PrimaryImmuneThrombocytopeniaITP#Antibody#Approved#monoclonal-antibody#Roche
Trials 1Status Recruiting
AntibodyLimited DatastaleGlaxoSmithKlinePhase 1

GSK3359609 (feladilimab, feladilimab (GSK3359609))

Neoplasms · Neoplasms

#Neoplasms#Antibody#Phase1#monoclonal-antibody#GlaxoSmithKline
Trials 1Status Active
AntibodyLimited DatastaleCTI BioPharmaPhase 3

fludarabine and rituximab (fludarabine and rituximab)

Non-Hodgkin's Lymphoma · Non-Hodgkin's Lymphoma

#Non-HodgkinsLymphoma#Antibody#Phase3#monoclonal-antibody#CTI
Trials 1Status Discontinued
AntibodyLimited DatastaleCTI BioPharmaPhase 3

fludarabine, rituximab, pixantrone (fludarabine, rituximab, pixantrone)

Non-Hodgkin's Lymphoma · Non-Hodgkin's Lymphoma

#Non-HodgkinsLymphoma#Antibody#Phase3#monoclonal-antibody#CTI
Trials 1Status Discontinued
AntibodyLimited DatastaleEli LillyPhase 2

fulzerasib; cetuximab N01 (fulzerasib; cetuximab N01)

Colorectal Cancer; KRAS G12C Mutant Advanced Solid Tumors · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#monoclonal-antibody#KRASG12CMutantAdvancedSolidTumor+1
Trials 1Status Recruiting
AntibodyLimited DatastaleEli LillyPhase 2

gemcitabine + cetuximab (gemcitabine + cetuximab)

Time to Progression · Time to Progression

#TimetoProgression#Antibody#Phase2#monoclonal-antibody#Eli
Trials 1Status Active
AntibodyLimited DatastalePfizerPhase 3

gemtuzumab ozogamycin (gemtuzumab ozogamycin)

Acute Myeloid Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#Antibody#Phase3#monoclonal-antibody#Pfizer
Trials 1Status Active
AntibodyLimited DatastaleArrys TherapeuticsPhase 2

pembrolizumab (Keytruda, grapiprant and pembrolizumab)

Non-small Cell Lung Cancer Adenocarcinoma · Non-small Cell Lung Cancer Adenocarcinom

#Non-smallCellLungCancerAdenocarc#Antibody#Phase2#monoclonal-antibody#Arrys
Trials 1Status Discontinued
AntibodyLimited DatastaleGilead SciencesPhase 2

the doxorubicin conjugate of milatuzumab (hLL1-DOX, hLL1-DOX (the doxorubicin conjugate of milatuzumab))

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#monoclonal-antibody#Gilead
Trials 1Status Discontinued
AntibodyLimited DatastaleSuZhou Stainwei Biotech Inc.Phase 1

hPV19 mAb (hPV19 mAb)

Solid Tumors · Solid Tumors

#SolidTumors#Antibody#Phase1#monoclonal-antibody#SuZhou
Trials 1Status Active
AntibodyLimited DatastaleHawaii Pacific HealthPhase 2

ranibizumab (Lucentis, high-dose ranibizumab)

PCV; Polypoidal Choroidal Vasculopathy · PCV

#PCV#Antibody#Phase2#monoclonal-antibody#PolypoidalChoroidalVasculopathy+1
Trials 1Status Active
AntibodyLimited DatastaleGruppo Italiano Malattie EMatol…Preclinical

idelalisib and rituximab (idelalisib and rituximab)

Chronic Lymphocytic Leukemia · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#Antibody#Preclinical#monoclonal-antibody#Gruppo
Trials 1Status Active
AntibodyLimited DatastaleUniversity Hospital, BordeauxPhase 3

immunomodulatory treatment by rituximab (immunomodulatory treatment by rituximab)

Mental Disorder · Mental Disorder

#MentalDisorder#Antibody#Phase3#monoclonal-antibody#University
Trials 1Status Recruiting
AntibodyLimited DatastaleSpectrum Pharmaceuticals, IncPhase 2

indium-111-ibritumomab tiuxetan (indium-111-ibritumomab tiuxetan)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#monoclonal-antibody#Spectrum
Trials 1Status Discontinued
AntibodyLimited DatastaleRochePhase 3

injection Combined Bevacizumab and Fasudil (injection Combined Bevacizumab and Fasudil)

Retinal Vein Occlusion · Retinal Vein Occlusion

#RetinalVeinOcclusion#Antibody#Phase3#monoclonal-antibody#Roche
Trials 1Status Active
AntibodyLimited DatastaleJinnah Postgraduate Medical Cen…Preclinical

injection Sekucinumab (injection Sekucinumab)

Erythrodermic Psoriasis · Erythrodermic Psoriasis

#ErythrodermicPsoriasis#Antibody#Preclinical#monoclonal-antibody#Jinnah
Trials 1Status Recruiting

49 / 52 pages

← PreviousNext →